Compare multi-agent consensus ratings, forecast paths, AI price targets, expected return, fundamentals, analyst disagreement, risks, and the investment thesis across short- and long-term horizons.

Ping An Insurance logo
2318.HKEX
Ping An Insurance
Financial Services | Insurance - Life

Ping An Insurance (Group) Company of China, Ltd. provides financial products and services in the People's Republic of China.

Flagship Insight

Why the Market Misprices This High-Yielding Financial Giant Amid Macro Fears

High consensus across reports reveals a deeply undervalued financial giant whose core underwriting engine is accelerating despite real estate headwinds. While geopolitical risks and domestic rate compression present persistent valuation friction, robust cash generation and a resilient dividend yield provide a strong margin of safety.

Forecast TimelineUpdated On Jul 03 2026

Ping An Insurance (2318) Stock Forecast and AI Rating

Recommendation

Small Buy

2027

1-Year

BUY

HK$60

+15.5%
2029

3-Year

N/A

HK$74

+31%
2031

5-Year

BUY

HK$88

+70%
+109% IF INCL. DIVS
LATEST DEEP FORECAST ANALYSIS BY iPULSE AI ENGINE |
Elon Musk (Visionary) advisor portraitSuperintelligence (Anthropologist) advisor portraitMachiavelli (Insider) advisor portraitRay Dalio (Strategist) advisor portraitWarren Buffett (Value Purist) advisor portraitMichael Burry (Vulture) advisor portraitSherlock Holmes (Whistleblower) advisor portrait

Visionary, Superintelligence, Insider, Strategist, Value Seeker, Vulture, Whistleblower, and more.

Research support only. We don't give financial advice.

Computed on these frontier AI models
Gemini AI model logoGeminiClaude AI model logoClaudeChatGPT AI model logoChatGPTGrok AI model logoGrok

Investment Thesis Takeaway

Interactive forecast chart

Expert Language
Explained Simply

Ping An represents a structurally sound financial and technological conglomerate trading at a steep discount to book value due to legacy real estate and geopolitical risk premiums. The core life and health underwriting engine is accelerating, driven by successful agency reforms and integrated health-tech ecosystems that establish high switching costs. While domestic interest rate compression and global capital flight present persistent headwinds, the sheer gravity of robust free cash flow generation and a consistent double-digit return on equity will drive a methodical valuation re-rating.

Key insights

  • Successful agency restructuring and integrated health-tech ecosystems drive double-digit New Business Value growth.
  • A consistent capital allocation track record provides a strong valuation floor through resilient dividend yields.
  • Proprietary artificial intelligence integration across underwriting and claims processing structurally lowers combined ratios.
  • Persistent geopolitical risk premiums and domestic yield curve compression act as the primary valuation caps.
  • Legacy real estate exposures are actively de-risked and provisioned, neutralizing systemic balance sheet tail risks.
  • Investors should focus on operating profit after tax rather than volatile statutory net income prints.
  • Divergent domestic monetary easing supports asset valuations while global capital remains structurally underweight.
Preparing your access...